The incomparable master of the legal thriller takes us deeper into the labyrinth that is the American justice system, always drawing us in with an irresistible hook, pulling the thread of tension tighter and tighter, and then knocking us out with a conclusion that's never "by the book."

With their new associate on board, Finley & Figg is ready to tackle a really big case, a case that could make the partners rich without requiring them to actually practice much law. An extremely popular drug, Krayoxx, the number one cholesterol reducer for the dangerously overweight, produced by Varrick Labs, a giant pharmaceutical company with annual sales of $25 billion, has recently come under fire after several patients taking it have suffered heart attacks. Wally Figg smells money.